Cocrystal Pharma, Inc.
(NASDAQ : COCP)

( )
COCP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.05%169.012.9%$366.95m
ZTSZoetis, Inc. Class A
-1.52%126.521.9%$222.59m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-2.32%6.742.0%$93.24m
MYLMylan N.V.
-2.01%18.523.2%$89.93m
TXMDTherapeuticsMD, Inc.
2.21%3.9324.9%$12.86m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.08%37.372.0%$5.85m
TAROTaro Pharmaceutical Industries Ltd.
-2.42%74.246.5%$3.24m
LFVNLifeVantage Corporation
1.57%14.253.3%$1.61m
ABEOAbeona Therapeutics, Inc.
-3.13%2.177.6%$1.33m
KINKindred Biosciences, Inc.
7.04%6.990.3%$0.74m
JAGXJaguar Animal Health, Inc.
-1.99%0.699.8%$0.71m
CPHIChina Pharma Holdings, Inc.
-5.04%0.250.1%$0.02m

Company Profile

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.